Table
2: Important conditions to be
evaluated associated to surgical management of LABC.
General |
Category |
Variables |
|
||
Tumor |
Tumor size |
- |
|||
|
Tumor condition |
Primary, recurrence;
breast, axillary cavum |
|||
|
Size of resection |
- |
|||
|
Type of resection |
R0, R1, R2 |
|||
|
Ulceration |
Absent, present |
|||
|
Time of surgery |
Up front; after
neoadjuvant therapy (chemotherapy +/- radiotherapy) |
|||
|
Response to previous
therapies |
Stable disease; disease
progression |
|||
|
Intention to treat |
Curative, palliative |
|||
|
Metastasis |
Absent; Oligometastatic;
symptomatic |
|||
|
Histology |
Histology; molecular
subtype |
|||
Flap technique |
Classical description;
variation |
- |
|||
|
Irrigation based |
Thoracoabdominal or
myocutaneous |
|||
|
Thoracoabdominal |
Irrigation based/ random;
lateral, medial |
|||
|
Myocutaneous |
Type |
|||
|
Skin grafts |
Absent; association with
flaps |
|||
|
Size of the flap |
- |
|||
|
Time of the surgical
procedure |
- |
|||
|
Hospitalization stay |
- |
|||
|
Antibiotics |
- |
|||
Complication |
Absent or present |
|
|||
|
Infection |
Primary, secondary to
necrosis |
|||
|
Necrosis |
Extension (tip,
extensive) |
|||
|
|
Depth (epidermolysis,
total skin necrosis) |
|||
|
Treatment of necrosis |
Surgical revision,
additional procedures: Expectant, local debridement, surgery with general
anaesthesia |
|||
|
Dehiscence |
- |
|||
|
Surgical healing time |
Local control; beginning
of the next adjuvant treatment |
|||
Patient |
Patient |
Age, BM, Smoking, Diabetes |
|||
|
Postoperative survival |
Comorbidities; Mortality
(chest wall resection) |
|||
|
Quality of life |
- |
|||
|
Secondary breast
reconstruction |
- |
|||
Follow up |
Local recurrence |
- |
|||
|
Local free survival |
- |
|||
|
Overall survival |
- |